Innovation in Alopecia Areata.
Luiza Kalil,
Brett King
Review
Dermatologic clinics
2025
5 citas
PubMed
DOI
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'haircited.com';
const params = 'pmid\u003D39542562';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
Study Design
- Tipo de estudio
- Review
- Población
- Patients with alopecia areata (review)
- Intervención
- Innovation in Alopecia Areata. None
- Comparador
- None
- Resultado primario
- Alopecia areata treatment outcomes
- Dirección del efecto
- Positive
- Riesgo de sesgo
- Unclear
Abstract
Advances in understanding of AA have led to the first approved therapies for this disease, and in the past two years, there have been three medicines approved for the treatment of severe alopecia areata. There are numerous clinical trials of novel therapeutics underway across the spectrum of AA.
TL;DR
None
Used In Evidence Reviews
Similar Papers
Annual review of nutrition · 2004
Secular trends in dietary intake in the United States.
664 citations
Journal of the American Academy of Dermatology · 2002
A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
372 citations
Journal of the American Academy of Dermatology · 2017
The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
343 citations
Current problems in dermatology · 2015
Alopecia areata.
322 citations
Drug design, development and therapy · 2019
Minoxidil and its use in hair disorders: a review.
320 citations
Open Access
Journal of cosmetic dermatology · 2021
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
315 citations
Open Access